These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 36039212)

  • 21. Invasive pulmonary aspergillosis in patients with acute respiratory syndrome by COVID-19.
    Sánchez Martín C; Madrid Martínez E; González Pellicer R; Armero Ibáñez R; Martínez González E; Llau Pitarch JV
    Rev Esp Anestesiol Reanim (Engl Ed); 2021 Apr; ():. PubMed ID: 34565575
    [TBL] [Abstract][Full Text] [Related]  

  • 22. COVID-19 Infection and Late Manifestation of Pulmonary Aspergillosis.
    Bhopalwala H; Mishra V; Do TV; Gudipati M; Ganti SS
    J Investig Med High Impact Case Rep; 2022; 10():23247096211063332. PubMed ID: 34984948
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fatal VAP-related pulmonary aspergillosis by
    Trovato L; Calvo M; Migliorisi G; Astuto M; Oliveri F; Oliveri S
    Respir Med Case Rep; 2021; 32():101367. PubMed ID: 33619451
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genomic and Phenotypic Analysis of COVID-19-Associated Pulmonary Aspergillosis Isolates of Aspergillus fumigatus.
    Steenwyk JL; Mead ME; de Castro PA; Valero C; Damasio A; Dos Santos RAC; Labella AL; Li Y; Knowles SL; Raja HA; Oberlies NH; Zhou X; Cornely OA; Fuchs F; Koehler P; Goldman GH; Rokas A
    Microbiol Spectr; 2021 Sep; 9(1):e0001021. PubMed ID: 34106569
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Underlying Conditions and Clinical Spectrum of Chronic Pulmonary Aspergillosis (CPA): An Experience from a Tertiary Care Hospital in Karachi, Pakistan.
    Iqbal N; Irfan M; Mushtaq A; Jabeen K
    J Fungi (Basel); 2020 Mar; 6(2):. PubMed ID: 32225054
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Atypical Presentation of
    Fiema M; Wlodarczyk A; Wojkowska-Mach J; Garlicki J; Gregorczyk-Maga I
    Microorganisms; 2022 Aug; 10(8):. PubMed ID: 36014048
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical manifestations, associated risk factors and treatment outcomes of Chronic Pulmonary Aspergillosis (CPA): Experiences from a tertiary care hospital in Lahore, Pakistan.
    Akram W; Ejaz MB; Mallhi TH; Syed Sulaiman SAB; Khan AH
    PLoS One; 2021; 16(11):e0259766. PubMed ID: 34767589
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical manifestations and outcomes of pulmonary aspergillosis: experience from Pakistan.
    Iqbal N; Irfan M; Zubairi AB; Jabeen K; Awan S; Khan JA
    BMJ Open Respir Res; 2016; 3(1):e000155. PubMed ID: 28074136
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epidemiology of Invasive Pulmonary Aspergillosis Among Intubated Patients With COVID-19: A Prospective Study.
    Bartoletti M; Pascale R; Cricca M; Rinaldi M; Maccaro A; Bussini L; Fornaro G; Tonetti T; Pizzilli G; Francalanci E; Giuntoli L; Rubin A; Moroni A; Ambretti S; Trapani F; Vatamanu O; Ranieri VM; Castelli A; Baiocchi M; Lewis R; Giannella M; Viale P;
    Clin Infect Dis; 2021 Dec; 73(11):e3606-e3614. PubMed ID: 32719848
    [TBL] [Abstract][Full Text] [Related]  

  • 30. COVID-19-associated subacute invasive pulmonary aspergillosis.
    Swain S; Ray A; Sarda R; Vyas S; Singh G; Jorwal P; Kodan P; Khanna P; Xess I; Sinha S; Wig N; Trikha A
    Mycoses; 2022 Jan; 65(1):57-64. PubMed ID: 34541719
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Invasive pulmonary aspergillosis in critically ill patients with severe COVID-19 pneumonia: Results from the prospective AspCOVID-19 study.
    Lahmer T; Kriescher S; Herner A; Rothe K; Spinner CD; Schneider J; Mayer U; Neuenhahn M; Hoffmann D; Geisler F; Heim M; Schneider G; Schmid RM; Huber W; Rasch S
    PLoS One; 2021; 16(3):e0238825. PubMed ID: 33730058
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A 10-year study reveals clinical and laboratory evidence for the 'semi-invasive' properties of chronic pulmonary aspergillosis.
    Chan JF; Lau SK; Wong SC; To KK; So SY; Leung SS; Chan SM; Pang CM; Xiao C; Hung IF; Cheng VC; Yuen KY; Woo PC
    Emerg Microbes Infect; 2016 Apr; 5(4):e37. PubMed ID: 27094904
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A 64-Year-Old Man Hospitalized for COVID-19 Pneumonia and Treated with Tocilizumab Who Developed Chronic Cavitary Pulmonary Aspergillosis.
    Adetiloye AO; Alladin F; Alaameri R; Valencia-Manrique JC; Badero O; Poor A
    Am J Case Rep; 2023 Mar; 24():e938359. PubMed ID: 36927852
    [TBL] [Abstract][Full Text] [Related]  

  • 34. COVID-19-Associated Pulmonary Aspergillosis, Fungemia, and Pneumocystosis in the Intensive Care Unit: a Retrospective Multicenter Observational Cohort during the First French Pandemic Wave.
    Bretagne S; Sitbon K; Botterel F; Dellière S; Letscher-Bru V; Chouaki T; Bellanger AP; Bonnal C; Fekkar A; Persat F; Costa D; Bourgeois N; Dalle F; Lussac-Sorton F; Paugam A; Cassaing S; Hasseine L; Huguenin A; Guennouni N; Mazars E; Le Gal S; Sasso M; Brun S; Cadot L; Cassagne C; Cateau E; Gangneux JP; Moniot M; Roux AL; Tournus C; Desbois-Nogard N; Le Coustumier A; Moquet O; Alanio A; Dromer F;
    Microbiol Spectr; 2021 Oct; 9(2):e0113821. PubMed ID: 34668768
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effective plasma concentrations of itraconazole and its active metabolite for the treatment of pulmonary aspergillosis.
    Nakamura Y; Matsumoto K; Sato A; Morita K
    J Infect Chemother; 2020 Feb; 26(2):170-174. PubMed ID: 31481305
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The clinical presentations of pulmonary aspergillosis in children with cystic fibrosis - preliminary report.
    Walicka-Serzysko K; Sands D
    Dev Period Med; 2015; 19(1):66-79. PubMed ID: 26003072
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Invasive pulmonary aspergillosis in the COVID-19 era: An expected new entity.
    Machado M; Valerio M; Álvarez-Uría A; Olmedo M; Veintimilla C; Padilla B; De la Villa S; Guinea J; Escribano P; Ruiz-Serrano MJ; Reigadas E; Alonso R; Guerrero JE; Hortal J; Bouza E; Muñoz P;
    Mycoses; 2021 Feb; 64(2):132-143. PubMed ID: 33210776
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Usefulness of Sōna Aspergillus Galactomannan LFA with digital readout as diagnostic and as screening tool of COVID-19 associated pulmonary aspergillosis in critically ill patients. Data from a multicenter prospective study performed in Argentina.
    Giusiano G; Fernández NB; Vitale RG; Alvarez C; Ochiuzzi ME; Santiso G; Cabeza MS; Tracogna F; Farías L; Afeltra J; Noblega LM; Giuliano CV; Garcia-Effron G
    Med Mycol; 2022 May; 60(5):. PubMed ID: 35394043
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of
    Takazono T; Ito Y; Tashiro M; Nishimura K; Saijo T; Yamamoto K; Imamura Y; Miyazaki T; Yanagihara K; Mukae H; Izumikawa K
    J Clin Microbiol; 2019 May; 57(5):. PubMed ID: 30842231
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incidence and Risk Factors of COVID-19-Associated Pulmonary Aspergillosis in Intensive Care Unit-A Monocentric Retrospective Observational Study.
    Gregoire E; Pirotte BF; Moerman F; Altdorfer A; Gaspard L; Firre E; Moonen M; Fraipont V; Ernst M; Darcis G
    Pathogens; 2021 Oct; 10(11):. PubMed ID: 34832526
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.